A 38-year-old man with newly diagnosed rheumatoid arthritis (RF-positive, anti-CCP-positive) is being evaluated for disease severity and prognosis. His ESR is 65 mm/hr and CRP is 28 mg/L. Which investigation would be most appropriate to assess the presence of erosive disease and guide intensity of DMARD therapy?

## Assessment of Erosive Disease in Rheumatoid Arthritis **Key Point:** Plain radiographs of hands and feet are the standard imaging investigation to detect bone erosions, which are a hallmark of RA and a key prognostic marker. Erosions indicate more aggressive disease and warrant intensive DMARD therapy. ### Why Plain Radiographs? **High-Yield:** Plain radiographs: - Detect cortical erosions (bone loss at joint margins) - Are reproducible and standardized for RA assessment - Are cost-effective and widely available - Form the basis of radiographic scoring systems (Larsen, Sharp/van der Heijde) - Correlate with functional disability and long-term prognosis - Are recommended in ACR/EULAR guidelines for baseline assessment ### Timing of Radiographic Changes 1. **Weeks 0–6:** Soft tissue swelling only (not visible on X-ray) 2. **Weeks 6–12:** Periarticular osteopenia appears 3. **Weeks 12–24:** Marginal erosions become visible 4. **Months 6–12:** Progressive erosions and joint space narrowing This patient is in the window (newly diagnosed, high inflammatory markers) where early erosions may be present and detection would guide aggressive therapy. **Clinical Pearl:** The presence of erosions at baseline predicts poor long-term outcomes and is an indication for biological DMARDs (TNF inhibitors, IL-6 inhibitors) rather than conventional monotherapy. ### Imaging Modality Comparison | Modality | Erosion Detection | Sensitivity | Cost | Availability | Clinical Use | |---|---|---|---|---|---| | Plain X-ray (hands/feet) | Yes (cortical) | 70–80% | Low | High | Baseline + annual | | Ultrasound (high-resolution) | Yes (early) | 85–90% | Moderate | Operator-dependent | Research, early detection | | MRI (wrist) | Yes (bone marrow edema, early erosions) | 95% | High | Low | Research, prognostication | | Serum complement | No erosions | — | Low | High | Immune complex activity | **Mnemonic:** **RADIOGRAPHS FIRST** — Radiographs (hands + feet) → Assess erosions → Determine severity → Intensify DMARD therapy → Obtain baseline for monitoring → Repeat annually → Annual progression assessment → Plan biologic therapy if erosive.